Skip to main content
Godavari Biorefineries Limited logo

Godavari Biorefineries Limited — Investor Relations & Filings

Ticker · GODAVARIB ISIN · INE497S01012 LEI · 335800HKLWUUCQI1DF36 BSE.NS Manufacturing
Open in API
Filings indexed 194 across all filing types
Latest filing 2025-07-07 Regulatory Filings
Country IN India
Listing BSE.NS GODAVARIB

About Godavari Biorefineries Limited

https://godavaribiorefineries.com

Godavari Biorefineries Limited specializes in the production of bio-based chemicals, ethanol, and sugar through an integrated biorefinery model. Utilizing sugarcane as the primary feedstock, the company manufactures a wide range of products including fuel-grade ethanol, extra neutral alcohol, and specialty chemicals such as ethyl acetate, 1,3-butanediol, and bio-based solvents. These products serve diverse applications in the pharmaceutical, flavor and fragrance, and paints and coatings sectors. The company prioritizes sustainable manufacturing and value-added chemical processes, leveraging research and development to create renewable alternatives to traditional petrochemicals. Its operations emphasize resource efficiency and the conversion of agricultural biomass into high-value industrial ingredients.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the validation of a European patent for an anti-cancer molecule by Godavari Biorefineries Limited. It is addressed to stock exchanges pursuant to SEBI regulations and provides information about the patent and the company's research activities. There are no financial statements, earnings data, or detailed management analysis. The document is informational and intended for public disclosure rather than a formal financial or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is a press release about a corporate development, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2025-07-07 English
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the granting of a patent for an anticancer molecule. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to material event disclosures. The document does not contain financial data, management discussion, or detailed report content. It is an announcement of a material event (patent grant) rather than a financial report or detailed filing. Given its brief nature and purpose as a regulatory disclosure, it fits best under Regulatory Filings (RNS).
2025-07-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges about the closure of the trading window for insiders in compliance with insider trading regulations. It specifies the period during which trading is prohibited due to the upcoming financial results announcement for the quarter ended June 30, 2025. The document does not contain any financial data, results, or detailed report content. It is a regulatory announcement related to trading restrictions ahead of financial results disclosure, not the financial results or report itself. Given the short length (1467 characters) and the nature of the content, this fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2025-06-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of analyst and institutional investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 2015, specifically Regulation 30, which pertains to disclosure of material events. The document mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges, but the document itself is not the presentation. The document is short (1862 characters) and serves as an announcement of the schedule and the availability of the presentation, not the presentation or report itself. Therefore, it fits the category of Investor Presentation (IP) related announcement, but since it is not the presentation itself, it is best classified as Regulatory Filings (RNS) as a general regulatory announcement about investor meetings and disclosures under SEBI regulations.
2025-06-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call for Godavari Biorefineries Limited covering Q4 and FY 2025 financial results. It includes detailed discussions of financial performance, operational updates, strategic initiatives, and a Q&A session with analysts. The text explicitly mentions it is an "earnings conference call" and contains actual financial data such as revenue, EBITDA, and PAT figures for the quarter and fiscal year. The presence of a full transcript with management commentary and Q&A confirms it is a Call Transcript (CT).
2025-05-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a formal notification addressed to stock exchanges about the schedule of analyst and institutional investor meetings. It references compliance with SEBI LODR Regulations and mentions that an investor presentation has been uploaded on the company's website and stock exchanges. The document explicitly states it is an intimation of the schedule of meetings and does not contain the presentation itself or detailed financial data. The document length is short (1852 characters), and it serves as an announcement rather than the actual investor presentation. Therefore, it fits the category of an Investor Presentation announcement or notification. According to the filing definitions, the closest match is Investor Presentation (IP), as it relates to meetings with investors and the presentation material is referenced as uploaded elsewhere. The document is not the presentation itself but an official notice about it, which aligns with the IP category rather than RPA or RNS because it specifically concerns investor meetings and presentation material.
2025-05-30 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.